HelloBetter
HelloBetter is a Berlin-based digital therapeutics company that delivers ten evidence-based mental health programs—six BfArM/DiGA-approved for anxiety, depression, and insomnia—to 120,000+ patients via physician prescription and statutory health insurance reimbursement in Germany, with active expansion into Switzerland and France.
- Company typePrivate
- Founded2015
- HeadquartersBerlin, Germany
- Headcount101–250
- GTM typeB2C
- OfferingSoftware
What HelloBetter does
HelloBetter GmbH is a Berlin-based digital therapeutics company founded in 2015 that develops app-delivered, evidence-based mental health therapy programs targeting conditions such as anxiety, depression, and insomnia. The company operates a portfolio of ten digital therapy programs, of which six have received approval from Germany's Federal Institute for Drugs and Medical Devices (BfArM) and are listed in the DiGA registry, enabling statutory-health-insurance reimbursement across Germany and a covered population of approximately 73 million people. The platform serves a cumulative base of more than 120,000 patients and is backed by 33 clinical studies, with the company recognized among the top three contributors to the scientific literature on digital health interventions for depression.
The underlying technology is built on clinically validated CBT- and CBT-I-based therapeutic content delivered through a mobile application rather than a novel machine-learning architecture, with AI capabilities introduced primarily through the MindFIT project — a stealth-stage initiative focused on personalization and adherence. HelloBetter has accumulated approximately €31M in disclosed funding across multiple venture rounds and strategic investments, with HealthCap, Expon Capital, HSBC Asset Management, Mutuelles Impact, and the Brandenburg Ministry cited among its backers.
HelloBetter's business model runs primarily through the German DiGA reimbursement pathway: physicians prescribe approved programs to patients, statutory health insurers cover the cost, and the company captures a per-prescription fee at framework-defined pricing. International expansion is underway, with Switzerland commercially launched in 2024 and France identified as the next target via engagement with the Haute Autorité de Santé (HAS) for national reimbursement — the company's first deliberate move outside the DACH region.
HelloBetter firmographics
Firmographics- Name
- HelloBetter
- Legal name
- HelloBetter GmbH
- Website
- https://hellobetter.de
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- HelloBetter is a Berlin-based digital therapeutics company that delivers ten evidence-based mental health programs—six BfArM/DiGA-approved for anxiety, depression, and insomnia—to 120,000+ patients via physician prescription and statutory health insurance reimbursement in Germany, with active expansion into Switzerland and France.
- Ownership category
- akta.pro rank
HelloBetter industry classification
Industry- Product category
- Digital Mental Health Therapeutics
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420)
- SIC
- Services-Health Services (8000), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Prescription Digital Therapeutics (PDT) (HLACANAB)
- akta.pro secondary industries
- Condition-specific Digital Therapeutics (DTx) (HLACANAA), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF)
Keywords
Where HelloBetter is headquartered
LocationHeadquarters
- HQ city
- Berlin
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
HelloBetter business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Digital Therapy Programs: Evidence-based digital therapeutics delivered via app, currently covered under Germany's DiGA reimbursement framework with 6 BfArM-approved programs. Future expansion planned through national reimbursement in France via HAS engagement.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels1 record
HelloBetter product offering
Product offeringCore offering
HelloBetter develops and delivers evidence-based digital therapeutics (DTx) for mental health conditions, currently offering ten digital therapy programs — six of which are BfArM-approved and reimbursed under Germany's DiGA framework. Programs are prescribed by doctors, accessed by patients via a dedicated app, and covered by statutory health insurance, with over 120,000 patients served to date.
Product overview
HelloBetter is a digital health company specializing in evidence-based digital therapeutics for mental health. The company operates a platform of ten digital therapy programs, six of which are BfArM-approved, serving over 120,000 patients. The portfolio includes the core HelloBetter Digital Therapy Programs and the in-development MindFIT product focused on AI-powered personalization and adherence enhancement.
Differentiator
Problem solved
Functional benefit
Products and services
- HelloBetter Digital Therapy Programs App-delivered, evidence-based digital therapeutic programs for mental health conditions including anxiety, depression, and insomnia; six of the ten programs are approved by Germany's BfArM and prescribed by physicians with reimbursement through statutory health insurance. Used by over 120,000 patients.
- MindFIT AI-based digital mental health product focused on enhancing user experience and adherence through personalization; funded with €3M from the Brandenburg Ministry and launched in stealth mode in November 2024.
Quantifiable outcome
- Over 120,000 patients have used HelloBetter's digital therapy programs
- +1 more outcomes
Companies that use HelloBetter
Customer profileNamed customers1 record
Segments2 records
Ideal customer profiles2 records
HelloBetter technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature1 record
HelloBetter partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights6 records
HelloBetter competitors and assessment
Company assessmentDirect peers
- Big Health: Big Health is a U.S.-based digital therapeutics company for mental health (Sleepio for insomnia, Daylight for anxiety), pursuing FDA SaMD pathways. It is a direct peer in evidence-based, prescription-grade digital mental health therapeutics targeting insomnia and anxiety, which overlap HelloBetter's core indications.
- Deprexis (Orexo): Orexo's Deprexis is an evidence-based, CE-marked digital therapeutic for depression. Like HelloBetter, it has a substantial clinical evidence base (it appears alongside HelloBetter in the systematic publication analysis) and competes for the same European depression-treatment prescribers and payors.
- GAIA AG: GAIA AG is a Hamburg-based competitor in the European DTx space, with multiple BfArM-approved DiGA listings for conditions including depression and anxiety. It is a direct DiGA-framework competitor pursuing the same prescription-reimbursement pathway in Germany.
- Akili Interactive: Akili Interactive is a prescription digital therapeutic company (EndeavorRx) and direct peer in the regulated PDTx category, demonstrating the same regulatory/clinical evidence model and prescription-reimbursement go-to-market approach, albeit currently focused on ADHD.
- SilverCloud Health (Amwell): SilverCloud Health is one of HelloBetter's closest peers: an evidence-based digital mental health platform offering CBT-based programs for depression, anxiety, and insomnia, with extensive clinical trials — co-identified with HelloBetter in top-three publications for digital health interventions for depression. Acquired by Amwell in 2021, providing scale distribution.
Emerging players
- Limbic: Limbic is a UK-based AI-driven mental health platform operating in NHS IAPT pathways, offering AI-supported self-referral and therapy matching. It is an emerging peer competing in evidence-based, regulated digital mental health delivery in another major European market.
- Woebot Health: Woebot Health is an AI-driven conversational mental health platform offering CBT-style interventions via chatbot. It is an emerging competitor that overlaps HelloBetter's anxiety/depression space and represents the AI-native delivery model HelloBetter's MindFIT project is moving toward.
Broad incumbents
- Calm: Calm is a large-scale consumer mental wellness and meditation platform, increasingly expanding into evidence-based therapy and employer channels. It represents the broad incumbent consumer brand competing for the same mental health patient population HelloBetter serves.
- Headspace Health: Headspace (now Headspace Health after combining with Ginger) is a broad incumbent in digital mental health, offering a consumer app and B2B therapy services. It competes for both consumer mindshare and employer/payor contracts that HelloBetter also targets via DiGA.
Others
- Mindstrong (now defunct) / Pear Therapeutics (now bankrupt): Pear Therapeutics was a high-profile PDTx pioneer that filed for bankruptcy in 2023 despite FDA approvals. It serves as a cautionary adjacent peer highlighting the structural risks of the PDTx business model that HelloBetter must navigate.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights7 records
Customer concentration
HelloBetter social profiles
Digital presenceHelloBetter compliance and trust
Trust signalCompliance1 record
HelloBetter financial estimates
Financial estimateRevenue estimate
Valuation estimate
HelloBetter leadership team
Management profileNumber of profiles
Profiles9 records
HelloBetter funding detail
Funding detailFunding overview
Funding rounds8 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
HelloBetter M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about HelloBetter
What does HelloBetter do?
HelloBetter develops and delivers evidence-based digital therapeutics (DTx) for mental health conditions, currently offering ten digital therapy programs — six of which are BfArM-approved and reimbursed under Germany's DiGA framework. Programs are prescribed by doctors, accessed by patients via a dedicated app, and covered by statutory health insurance, with over 120,000 patients served to date.
Is HelloBetter a public or private company?
HelloBetter is a private company. It is classified as venture growth investor backed and is currently operating.
When was HelloBetter founded?
HelloBetter was founded in 2015. It employs 101 to 250 people.
Where is HelloBetter based?
HelloBetter is headquartered in Berlin, Germany, in the Europe region.
How does HelloBetter make money?
One revenue line is on record: digital Therapy Programs.
Who are HelloBetter's main competitors?
Direct peers on record are Big Health, Deprexis (Orexo), GAIA AG, Akili Interactive and SilverCloud Health (Amwell). Emerging players are Limbic and Woebot Health. Broad incumbents are Calm and Headspace Health. Mindstrong (now defunct) / Pear Therapeutics (now bankrupt) is listed as an others.
Does HelloBetter have an API?
No public API is recorded for HelloBetter.
What industry is HelloBetter in?
HelloBetter's product category is Digital Mental Health Therapeutics. Its primary akta.pro industry code is HLACANAB, Prescription Digital Therapeutics (PDT), with a secondary code of HLACANAA, Condition-specific Digital Therapeutics (DTx). Its NAICS code is 621420 and its SIC code is 8000.